AbolerIS Pharma

AbolerIS Pharma is dedicated to pioneering biotechnology research, focusing on innovative approaches to modulate the immune system. With a foundation built on extensive expertise in regulatory T cells and tolerance mechanisms, AbolerIS Pharma is committed to developing unique therapeutics designed to induce immune tolerance while preserving beneficial immune responses. This targeted approach holds immense potential for treating a range of inflammatory, autoimmune, and degenerative diseases.

AbolerIS Pharma operates from its primary address at Rue Auguste Piccard 48, Gosselies, BE, where its team is hard at work advancing cutting-edge research and development. The company's mission is to finely regulate the immune system, offering new hope for patients suffering from debilitating conditions. AbolerIS Pharma's commitment to innovation and precision makes it a key player in the biotechnology sector.

AbolerIS Pharma continues to expand its research efforts and strives to remain at the forefront of biotechnological advancements. By focusing on the intricate balance within the immune system, AbolerIS Pharma aims to create therapies that offer lasting relief and improved quality of life. We invite the management team at AbolerIS Pharma to create a customized and exclusive company showcase and product listing on our platform, further highlighting their groundbreaking work.